A patient sits down and asks for “Botox,” but what she actually wants is smoother crow’s feet and a softer frown line by Friday. Whether that’s delivered with Botox or Bocouture is a decision that sits with the aesthetic practitioner and prescriber, not the patient’s brand recall — and it’s a decision that should be made on units, reconstitution behaviour and licensing, not on which name is more familiar.
Bocouture Botox comparisons come up constantly in UK clinics because both are botulinum toxin type A, both are prescription-only medicines, and both are licensed for upper facial lines. But they are not interchangeable vial-for-vial, and treating them as if they are is one of the more common dosing errors newer injectors make. This piece sets out what actually differs, how to handle both products safely, and where to buy authenticated stock.
What’s Actually Different Between Botox and Bocouture
Botox (onabotulinumtoxinA, manufactured by Allergan/AbbVie) and Bocouture (incobotulinumtoxinA, manufactured by Merz Aesthetics) both work the same way at a molecular level: they cleave SNAP-25 at the neuromuscular junction, blocking acetylcholine release so the treated muscle can’t contract until new nerve terminals sprout. That’s why the effect is temporary and why both are dosed against muscle bulk and activity rather than skin.
The formulation is where they part ways. Botox is a complex formulation that includes accessory proteins alongside the active toxin. Bocouture is a “naked” formulation, stripped of the complexing proteins that carry no role in the neuromuscular blocking effect but are thought to contribute to antibody formation with repeated, long-term use. Bocouture also doesn’t need refrigeration before reconstitution, which removes a cold-chain concern for clinics running outreach days or working across sites — Botox does require cold storage.
Genuine current frustration for many practitioners is unit confusion. A unit of Botox is not the same as a unit of Bocouture, Azzalure or Dysport — each manufacturer’s potency assay is proprietary, so doses don’t convert on a simple ratio. The manufacturer’s licensing documentation is explicit that unit doses are not interchangeable between preparations. Comparative studies have generally shown onabotulinumtoxinA and incobotulinumtoxinA performing at close to a 1:1 ratio in practice, which is why many practitioners switch across at similar numbers — but that’s an observed clinical pattern, not an official conversion, and it shouldn’t be treated as one on the first switch.
Botox 50 Units, 100 Units and 200 Units: Choosing the Right Vial Size
What Botox Is Licensed For
Botox is licensed in the UK for the temporary improvement of moderate to severe glabellar lines, and is widely used off-label for forehead lines and lateral canthal lines (crow’s feet) as part of standard upper-face treatment. It also carries licensed indications outside aesthetics, including hyperhidrosis, chronic migraine and overactive bladder — relevant if a clinic also runs medical toxin lists alongside cosmetic work.
Botox Areas and Realistic Unit Ranges
Botox Areas commonly treated in aesthetic practice include the glabella (typically 20 units), the frontalis (10–20 units depending on muscle activity and brow position), and the lateral orbicularis oculi for Crows Feet Botox (typically 8–12 units per side). Total upper-face treatments commonly fall between 30 and 64 units, which is why vial size selection matters at a business level: a 50-unit vial suits single-patient, single-area work with minimal wastage, while 100-unit and 200-unit vials reduce the per-unit cost for clinics running a full day of combined upper-face treatments or treating larger muscle groups such as masseter.
Caution is needed with Botox Under Eyes, referring to the lower orbicularis oculi and infraorbital area. This zone sits close to the depressor muscles that support the lower eyelid, and over-treatment or diffusion into this area is a recognised cause of lower lid malposition and scleral show. Conservative dosing, precise depth and wide spacing from the inferior orbital rim reduce this risk.
Reconstituting Botox
Botox 50 Units, Botox 100 Units and Botox 200 Units are all supplied as a lyophilised powder and must be reconstituted with preservative-free 0.9% sodium chloride before use. Standard practice is to introduce the saline gently down the inside wall of the vial rather than injecting it directly onto the powder, to avoid denaturing the protein through excess agitation or foaming. Dilution volume is a clinical decision, not a convenience choice — the volume the toxin is reconstituted in affects how far it diffuses from each injection point, which matters most in delicate areas like the periorbital region.
Once reconstituted, Botox has a limited shelf life and must be stored at 2–8°C and used within the timeframe set out in the product licence. Vials should never be refrozen or reused beyond the reconstitution window stated in the licensing documentation.
Botox Side Effects and the Mistakes That Cause Them
Botox side effects are typically local and short-lived: bruising, swelling, redness and mild headache at or near the injection site. Ptosis is the complication practitioners fear most, and it’s almost always the result of diffusion into the levator palpebrae superioris — usually from injecting too close to the orbital rim, using too high a volume, or massaging the treated area post-treatment.
The MHRA has recently strengthened safety warnings across all licensed botulinum toxin type A products following rare reports of the toxin’s effect spreading beyond the treated area, a condition known as iatrogenic botulism. Practitioners should be briefing patients on the warning signs of toxin spread — difficulty swallowing, slurred speech, breathing difficulty or unexpected muscle weakness — and advising immediate medical attention if these appear, even days or weeks after treatment. The risk rises with higher doses and with use outside licensed indications or approved injection sites, which is another argument for staying within established unit ranges rather than chasing faster results with heavier dosing.
Bocouture 50 Units and 100 Units: The Merz Alternative
What Sets Bocouture Apart
Bocouture is manufactured by Merz Aesthetics UK Ltd, and the Bocouture Merz formulation shares its therapeutic profile with Xeomin, the medical-indication version of the same molecule. Because it’s formulated without complexing proteins, it’s often positioned as the lower-immunogenicity option for patients who’ve had years of toxin treatment elsewhere, or for those specifically asking about a “purer” product. It’s licensed for glabellar frown lines, lateral periorbital lines (crow’s feet) and horizontal forehead lines in adults under 65, where the severity of these lines has a meaningful psychological impact on the patient.
Bocouture Units Per Area
Bocouture Units Per Area broadly mirror Botox at a similar overall dose, given the roughly 1:1 clinical equivalence practitioners typically observe. Clinical trial data on combined upper-face treatment used doses of 54 to 64 units across the glabella, forehead and lateral periorbital lines together, with the majority of treated patients showing a clear response at the maximum-contraction assessment point compared with placebo. As with Botox, exact per-area dosing should be adjusted for muscle bulk, patient sex and treatment history rather than applied as a fixed number.
Reconstituting Bocouture 100 Units
Bocouture Reconstitution 100 Units follows the same principle as the 50-unit vial: dissolve with preservative-free 0.9% sodium chloride, introduced gently down the vial wall to prevent foaming, and use within the timeframe specified in the product’s Summary of Product Characteristics. Bocouture’s key practical advantage shows up before reconstitution, not after — the unopened vial is stable at room temperature (below 25°C) for up to three years, removing the cold-chain requirement Botox carries in storage. Once reconstituted, both products should be treated the same way and refrigerated for the remainder of their use window.
When Bocouture 50 Units Makes Sense
Bocouture 50 Units is the practical choice for single-area treatment or lower-volume clinic days, keeping wastage down where a full 100-unit vial wouldn’t be used within its post-reconstitution window. Clinics treating multiple patients per session, or combining glabella, forehead and crow’s feet in one appointment, generally find the 100-unit vial more cost-efficient per unit delivered.
Making the Clinical Choice
Neither product is objectively superior — the decision comes down to patient history, clinic logistics and client expectations rather than brand hierarchy.
Botox may suit clinics where clients specifically request it by name, where non-cosmetic indications like hyperhidrosis or migraine are also offered, or where an established supply relationship and refrigerated storage are already in place.
Bocouture may suit clinics prioritising a lower-protein formulation for patients with treatment histories or antibody concerns, clinics running mobile or multi-site work where room-temperature storage before reconstitution is genuinely useful, or practices working to a tighter per-treatment cost.
Many UK clinics stock both and let the patient’s history and the treatment plan decide rather than defaulting to one brand for every booking. Whichever is chosen, the toxin must come from a verified, licensed supply chain — counterfeit and diverted botulinum toxin remains one of the most serious safety risks in UK aesthetics, and product provenance should never be assumed.
Sourcing Genuine Stock and Prescribers
Every batch matters here. Ordering Botox 50 Units, Botox 100 Units or Botox 200 Units through Faces Pharmacy links every vial to a registered prescriber and a GPhC-approved supply chain, so batch numbers and provenance are traceable from order to injection. The same applies on the Merz side — Bocouture 50 Units and Bocouture 100 Units are available through the same verified pharmacy route.
FAQs
Is Bocouture the same as Botox?
No. Both are botulinum toxin type A and work the same way in muscle, but they’re different formulations from different manufacturers — Botox contains complexing proteins, Bocouture doesn’t — and their units are not directly interchangeable.
How many units of Bocouture do I need per area?
Dosing broadly mirrors Botox at a similar total dose, with combined upper-face treatments typically in the 54–64 unit range across the glabella, forehead and crow’s feet. Exact amounts should be adjusted per patient rather than fixed.
What are the main side effects of Botox and Bocouture?
Both carry a similar side effect profile: temporary bruising, swelling, redness and occasional headache at the injection site. Rare but serious risks include ptosis and, very rarely, spread of toxin effect beyond the treated area, which requires immediate medical attention if symptoms appear.
Can I switch a patient from Botox to Bocouture?
Yes, but not on an automatic unit-for-unit basis. Clinical experience suggests a roughly 1:1 ratio works for most patients, but this is an observed pattern rather than a licensed conversion, so the first treatment on a new product should be assessed and adjusted as needed.
Where can I buy genuine Botox or Bocouture in the UK?
Only through a licensed pharmacy with a registered prescriber attached to the order, such as Faces Pharmacy. Buying from unverified sellers carries a real risk of counterfeit or diverted product.